Look to these tools to improve your AI coding practices and the quality, security, and reliability of your AI-generated code.

Karpathy CLAUDE.md ten rules: a document attributed to Andrej Karpathy began circulating Friday, adding six agent self-check ...

We at WIRED know that one of the best ways to save on essential (often price) tech is buying through a trusted retailer like Newegg, and that’s why we have a WIRED-exclusive promo code, valid only on ...

Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...

Linear error-correcting codes form the mathematical backbone of modern digital communication and storage systems, but identifying champion linear codes (linear codes achieving or exceeding the best ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

AI coding agents have become one of the fastest-growing categories in enterprise software. In the span of just a few years, these development tools have evolved from simple autocomplete assistants ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...